Objectives: S100 protein has been used as a marker for cerebral injury. Studies have reported lower levels in off-pump coronary artery surgery (CABG) compared to on-pump surgery. However, most of these are flawed as S100 from extracerebral sources was included (e.g. blood from cardiotomy suckers). Microemboli (high-intensity transient signals or HITS) during CABG have been implicated as a cause of postoperative neurocognitive dysfunction. The aim of this study was to compare the number of HITS during on-pump and off-pump CABG, measure S100 accurately by excluding extracerebral sources, and assess whether any changes in S100 were related to HITS. Methods: Thirty-five patients admitted for CABG were randomised to on-pump ðn ¼ 20Þ or off-pump ðn ¼ 15Þ surgery. Bilateral transcranial Doppler ultrasonography was performed on the middle cerebral artery to detect HITS. S100 was measured preoperatively, at termination of bypass in on-pump surgery, at completion of anastomoses in off-pump surgery, and 48 h postoperatively. A cell saver was used instead of cardiotomy suction in the on-pump group in order to limit extracerebral contamination of the S100 assay. Results: The number of HITS was 2016^1897 during on-pump and 16^21 during off-pump surgery ðP , 0:0001Þ: In on-pump surgery S100 increased from 0.05^0.03 to 0.50^0.28 mg/l ðP , 0:0001Þ at termination of bypass. In off-pump surgery S100 increased from 0.08^0.05 to 0.35^0.20 mg/l ðP , 0:0001Þ at completion of anastomoses. The mean intraoperative S100 in the on-pump group was 1.6 times greater compared to that in the off-pump group (95% CI 0.88-2.8; P ¼ 0:1). There was no evidence of a relationship between S100 and HITS in both groups. By 48 h S100 decreased to 0.22^0.14 mg/l in the on-pump and 0.21^0.09 mg/l in the off-pump group (P , 0:0001; compared to the preoperative value). Conclusions: We have demonstrated a significantly higher number of cerebral microemboli in patients undergoing on-pump compared to off-pump CABG. By limiting contamination from extracerebral sources, we have shown S100b levels during on-pump CABG one and a half times greater than that in off-pump, although this did not reach statistical significance. In addition, we have shown no correlation between S100b and the total microemboli count, possibly because of the small numbers in this study. q
Introduction
Neurocognitive injury is a significant problem after cardiac surgery, with an incidence as high as 50% at discharge from hospital. [1] . Apart from diffuse cerebral injury as a result of hypoperfusion and the systemic inflammatory response, cerebral emboli are thought to be the main cause of neurocognitive dysfunction and stroke [2 -5] . The majority of microemboli are generated as a result of manipulation and instrumentation of the heart and aorta, and from the pump circuitry [6] . With the advent of off-pump coronary artery bypass surgery (CABG), generation of microemboli from these sources is avoided [7] .
A number of biochemical markers have been investigated as a possible marker of cerebral injury, of which S100b protein is thought to be a sensitive, albeit nonspecific, indicator of central nervous damage [8, 9] . S100b is a 21-kDa acidic calcium binding which exists in several isoforms [10] . The presence of S100b in serum is an indication of neuronal damage and increased permeability of the blood -brain barrier [8] .
Previous studies have investigated the role of S100b as an indicator of cerebral injury after cardiac surgery [11 -13] . However, early studies did not account for other sources of S100b, such as mediastinal fat and shed blood in the mediastinum. These extracerebral sources of S100b are returned to the patient via cardiotomy suckers and as a result serum S100b levels are falsely elevated [14, 15] .
The aim of this study was to compare the number of microemboli (high-intensity transient signals or HITS) between on-pump and off-pump CABG, to accurately measure levels of S100b by excluding contamination from extracerebral sources, and to determine if there is a correlation between intraoperative cerebral microemboli and S100b levels.
Materials and methods

Patient population and selection criteria
Approval for the study was obtained from the local ethics committee and all patients had given written informed consent. Between July and October 2002, 35 patients admitted for first time elective CABG were randomised to on-pump (group A; n ¼ 20) or off-pump (group B; n ¼ 15) surgery. Block randomisation was carried out by an independent observer on the morning of surgery. This individual would open sealed opaque envelopes containing a card that would indicate treatment allocation. Exclusion criteria for entry into the study were carotid artery stenosis; previous cerebrovascular or psychiatric disease; absence of a temporal acoustic window for transcranial Doppler monitoring; concomitant surgery; q-wave myocardial infarction (MI) in the past 6 weeks, and very poor left ventricular function. Baseline characteristics including age, sex, history of hypertension, diabetes, myocardial infarction, peripheral vascular disease, New York Heart Association (NYHA) class, ejection fraction and EuroSCORE were recorded (Table 1) .
Anaesthesia
Premedication was administered with morphine and hyoscine. Anaesthesia was induced with either fentanil and vecuronium or alfentanil, morphine and pancuronium. Maintenance anaesthesia was provided with isoflurane or propofol.
On-pump CABG
On-pump CABG was performed with a Stöckert S3 roller pump (Stöckert, Munich, Germany), membrane oxygenators (Avant Sorin, Mirandola, Italy), and a 40 mm arterial blood filter (Dideco, Mirandola, Italy). A microbubble sensor (Stöckert) was incorporated in the pump circuit to detect microbubbles. Microbubbles greater than 250 mm in diameter would trigger an alarm. Moderate hypothermia (32 8C) and pH-stat management were used. Myocardial protection was achieved with cold antegrade blood-based cardioplegia. Perfusion pressure was kept at $ 60 mmHg and a pump flow of 2 -2.4 l/min per m 2 was maintained throughout cardiopulmonary bypass (CPB). Blood from cardiotomy suckers was separated from the pump circuit and washed with a cell saver (Dideco). In this way recirculation of extracerebral sources of S100b was minimised. After the distal anastamoses had been completed, the aortic cross-clamp was removed and the proximal anastomoses were carried out using a side-clamp on the aorta.
Off-pump CABG
Off-pump CABG was conducted via a median sternotomy. A heparin dose of 150 IU/kg was given to maintain an activated clotting time (ACT) $ 400 s. Occlusion and stabilisation of the target coronary artery was achieved with the use of silastic snares and the CTS Retractor (Cardio Thoracic Systems Inc, Cupertino, CA). All distal anastomoses were performed first. The proximal anastomoses were subsequently fashioned onto the aorta with the use of a single side-clamp. Near normothermia (35 8C) was maintained using warmed fluids and a heating mattress. Systolic blood pressure was kept $ 70 mmHg. 
Transcranial Doppler ultrasound (TCD)
All patients underwent bilateral middle cerebral artery TCD monitoring using a Nicolet/EME companion II machine (Eden Medizinische Elektronik GmbH, Kleinstheim, Germany), which uses a 128-point colourcoded fast Fourier transform. The middle cerebral arteries (MCA) were isonated with two 2-MHz EME probes that were fixed to the transtemporal widows with a Welder fixation headset (SciMed, Bristol, UK). The MCA was identified at a depth of 48-58 mm. Power was set at 48%, sweep speed maintained at 5.1 s and the sample volume kept constant at 10 mm. The Doppler sound was turned off during monitoring so that the surgeon was blinded to the number and timing of microemboli. The Doppler signals were recorded onto digital audio tape (Sony TCD-D8 DAT recorders) and then played back through the TCD system for off-line analysis at a later date. A single observer, who was blinded to patient details and treatment group, carried out analysis of the recordings for microemboli. Embolic signals were defined as short duration HITS and identified according to standard consensus criteria previously published [16] . An intensity threshold of 7 dB was one of the criteria used to distinguish HITS from artefact. Times of various surgical manipulations were noted. During on-pump CABG the times noted were as follows: aortic cannulation and decannulation, initiation and termination of CPB, application and removal of cross-clamp and side-clamps. In off-pump CABG, times when the heart was lifted, when the stabiliser was applied and removed, and when the sideclamp was applied and released were noted. HITS were counted within 1 min of each surgical manipulation and the total number of HITS for the whole procedure was determined for each patient. Monitoring commenced on opening of the pericardium and continued throughout the operation.
Serum S100b analysis
Venous blood samples for S100b were obtained prior to induction of anaesthesia, at termination of CPB in group A, upon completion of anastomoses in group B, and at 48 h. The samples were centrifuged, cooled and stored within 1 h and subsequently analysed in batches. All samples were coded and thus analysis of S100b was carried out without knowledge of patient details or treatment group. Serum S100b levels were measured by a monoclonal 2-site immunoradiometric assay (Sangtec 100 LIA assay: Sangtec Medical AB, Bromma, Sweden). The functional detection limit of the assay is 0.02 mg/l. A concentration greater than 0.15 mg/l was considered to be elevated.
Statistical analysis
All statistics were performed using Stata version 8.0 for windows (Stata Corporation, TX, USA). Results for continuous variables are represented as mean^SD and results for categorical variables are expressed as number (percent). Age and EuroSCORE are shown as median with interquartile range (IQR). Continuous variables that were normally distributed were compared with unpaired t-tests and non-normally distributed variables were compared with Mann -Whitney tests. The x 2 test was used to compare categorical variables. Intraoperative and postoperative S100b values were compared to preoperative levels using paired t-tests on raw or log transformed data. Comparison of intraoperative S100b between the two groups was carried out by analysis of covariance, with the preoperative level as a covariate. Correlation between intraoperative S100b level and HITS count was calculated using the Spearman correlation test.
Results
Baseline characteristics of the two groups are shown in Table 1 . Although there were more patients in group A with moderate left ventricular function, the median EuroSCORE was the same for both groups. One patient in group A suffered a postoperative stroke involving the cerebellum, pons and thalamus on the ninth postoperative day.
More patients in group A had triple vessel coronary artery disease, and more bypass grafts were performed in this group (Table 2) . No patients in the off-pump group were converted to on-pump surgery. There were no jump grafts or pedicled grafts used in either group.
The mean number of HITS was significantly greater during on-pump CABG (2016^1897 vs 16^21, P , 0:0001). In group A the largest number of HITS was noticed on initiation of CPB, followed by removal of the aortic cross-clamp and side-clamp (Fig. 1) . The patient who succumbed to a postoperative stroke on day nine had a total HITS count above 1700. In group B, release of the sideclamp resulted in the highest number of HITS (Fig. 2) .
The values for S100b for the two groups are shown in Table 3 . For both groups there was a significant rise in intraoperative S100b titres from preoperative levels (0.05^0.03 to 0.50^0.28 mg/l, P , 0:0001 in group A; 0.08^0.05 to 0.35^0.20 mg/l; P , 0:0001 in group B). Although the intraoperative S100b level during on-pump CABG was 1.6 times greater than that during off-pump, the difference was not statistically significant. In addition there was no correlation between the HITS count and intraoperative S100b level in either group (Fig. 3) . 
Discussion
Although the incidence of overt stroke after elective CABG remains about 3%, neurocognitive impairment after cardiac surgery is an increasingly important problem, especially as the population of patients undergoing CABG becomes older [17] . One of the main mechanisms underlying neurocognitive dysfunction is thought to be cerebral microemboli [5] .
We have shown that there is a significantly higher number of intraoperative cerebral microemboli in patients undergoing on-pump CABG compared to off-pump surgery. The few HITS that were detected in the off-pump group arose during lifting of the heart and removal of the sideclamp. The mean HITS count of this study in the on and offpump groups is similar to that reported by Bowles and colleagues [7] . There is, however, a wide variation in the number of HITS within the on-pump group. One reason could be due to different degrees of aortic atherosclerosis amongst these patients. A recent study by Mackensen has shown that patients with extensive atherosclerosis of the ascending aorta are more prone to cerebral embolisation during CABG. Therefore, manipulations of the aorta such as cannulation and clamping will result in increased cerebral embolisation in patients who have a significant degree of aortic atheroma [18] .
In addition, the number of HITS upon applying and removing the side-clamp in the on-pump group is higher than that in off-pump CABG. One reason might be that the 'sandblasting' effect from the high-velocity jet exiting the aortic cannula will exacerbate any injury to the aortic wall e.g. dislodgment of atheroma after removal of a side-clamp. As a result the combined process of the sandblasting effect and application/removal of the side-clamp will lead to a higher number of HITS in on-pump CABG, compared to that in off-pump, at the corresponding time points.
Measurement of S100b protein has been used to identify cerebral injury after CABG [19] . However, S100b from non-cerebral sources is thought to elevate the overall S100b level, thus limiting usefulness of this assay [14, 15] . One of the main mechanisms whereby extracerebral sources of S100b are introduced is via cardiotomy suckers. Cardiotomy suckers return shed mediastinal blood to the patient and it has been shown that mediastinal blood contains a high concentration of S100b [20] . In addition, experiments in dogs have shown that cardiotomy suckers are probably responsible for passage of lipid microemboli to the brain and formation of small capillary arterial dilatations [21] . We have avoided direct return of blood from cardiotomy suckers in this study and used a cell-saver instead to collect and wash mediastinal blood before transfusing it back to the patient. In this way the non-cerebral contribution to the S100b assay is kept to a minimum, and unnecessary allogenic blood transfusion avoided. We measured S100b 48 h postoperatively as a previous study by Jönsson has shown correlation of S100b level measured at this time with size of cerebral infarction identified on CT scanning [19] . The mean intraoperative levels of S100b achieved in our study is much lower than that reported in previous work comparing on-pump with off-pump CABG [13, 22] . It is possible that in Diegeler's study the high S100b level in the on-pump group is due to recirculation of activated leucocytes and mediastinal fat via cardiotomy suckers [13] . Anderson and colleagues study have reported S100b levels during on-pump CABG 10 times the order of magnitude than that found after off-pump surgery [22] . Even though no autotransfusion was carried out postoperatively, a limitation of Anderson's study is that no arterial filter was used in the on-pump circuitry. There is strong evidence to show that arterial filters reduce the number of microemboli passing to the brain and protect against neuropsychological impairment. [5, 23] .
Our S100b results concur with work done by Jönsson's group who showed that using a cell-saver in on-pump surgery, and not directly autotransfusing blood from cardiotomy suckers, limits extracerebral contamination of the assay [20] .
Having accounted for factors such as cardiotomy suckers and arterial filters in our study, we found intraoperative S100b levels during on-pump CABG one and a half times greater than that in off-pump, although this did not reach statistical significance. In addition, even though the difference in microemboli counts between the two groups was highly significant, there was no correlation between S100b and microemboli count, possibly because of the small numbers in our study. Grocott et al. have reported that there is a correlation between intraoperative microemboli and serum S100b [24] . However, the mean S100b at the end of bypass achieved in that study is almost five times greater than the equivalent level here, possibly as a result of use of cardiotomy suckers.
Despite randomisation of patients, the off-pump group had fewer bypass grafts compared to the on-pump group. This finding has been reported by others [25] . It may be that the off-pump technique raises the threshold for grafting smaller vessels.
It is possible that cerebral microemboli are not the cause of S100b elevation, and release of S100b could occur as a result of a generalised increased permeability of the bloodbrain barrier during CPB. In addition, as Anderson and colleagues have shown, there is a small rise in S100b soon after sternotomy and before CPB is instituted [14, 15] . This implies that not all the extracerebral sources of S100b are eliminated by avoiding cardiotomy suckers and that the surgical procedure itself causes an increase in S100b. However, before discounting the link between embolic induced ischemia and rise of S100b, a larger study with the same precautions taken in this investigation to limit extracerebral contamination of the S100b assay is required. Detailed neurocognitive testing can be conducted to correlate any elevation of S100b with neurocognitive dysfunction.
